A citation-based method for searching scientific literature

G Parmigiani, D Berry, O Aguilar. Am J Hum Genet 1998
Times Cited: 491

List of shared articles

Times cited

Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Melissa K Frey, Rohini V Kopparam, Zhen Ni Zhou, Jessica C Fields, Ama Buskwofie, Ann D Carlson, Thomas Caputo, Kevin Holcomb, Eloise Chapman-Davis. Cancer 2019

A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.
Ana F Best, Margaret A Tucker, Megan N Frone, Mark H Greene, June A Peters, Hormuzd A Katki. Cancer Epidemiol Biomarkers Prev 2019

Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
Ava Willoughby, Paul R Andreassen, Amanda Ewart Toland. J Pers Med 2019

Implementing a Population-Based Breast Cancer Risk Assessment Program.
Erica Silver, Neil Wenger, Zhuoer Xie, David Elashoff, Kristina Lee, Lisa Madlensky, Jacqueline Trent, Antonia Petruse, Liliana Johansen, Arash Naeim. Clin Breast Cancer 2019

Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan.
Fei-Hung Hung, Yong Alison Wang, Jhih-Wei Jian, Hung-Pin Peng, Ling-Ling Hsieh, Chen-Fang Hung, Max M Yang, An-Suei Yang. Sci Rep 2019

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Noura S Abul-Husn, Emily R Soper, Jacqueline A Odgis, Sinead Cullina, Dean Bobo, Arden Moscati, Jessica E Rodriguez, Ruth J F Loos, Judy H Cho, Gillian M Belbin,[...]. Genome Med 2019